Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11033-019-04727-5.pdf
Reference29 articles.
1. Inns J, James V (2015) Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease. Breast 24:364–369. https://doi.org/10.1016/j.breast.2015.04.001
2. Serpico D, Molino L, Cosimo S, Di (2014) microRNAs in breast cancer development and treatment. Cancer Treat Rev 40:595–604. https://doi.org/10.1016/j.ctrv.2013.11.002
3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):432–444. https://doi.org/10.1016/S0140-6736(11)61625-5
4. Friese CR, Harrison JM, Janz NK, Morrow M, Li Y, Hamilton AS et al (2018) Treatment-associated toxicities reported by patients with early-stage invasive breast cancer. Cancer 123(11):1925–1934. https://doi.org/10.1002/cncr.30547
5. Weidle UH, Dickopf S, Hintermair C, Kollmorgen G, Birzele F, Brinkmann U (2017) The role of micro RNAs in breast cancer metastasis: preclinical validation and potential therapeutic targets. Cancer Genom Proteom 15(1):17–39. https://doi.org/10.21873/cgp.20062
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Impact of miR-122 on Cancer;Current Pharmaceutical Biotechnology;2024-09
2. Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases;MedComm;2024-07-15
3. Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement;Biochemia medica;2024-06-15
4. A label-free electrochemical biosensor based on PBA-Au-MXene QD for miR-122 detection in serum samples;Microchimica Acta;2023-11-24
5. The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver;International Immunopharmacology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3